How many biotech companies are around here? Are the same forces at work in the article below going to cause any pain for the local OC employers?
Bristol-Myers to Eliminate 4,800 Jobs
http://www.nytimes.com/2007/12/06/business/06bristol.html?_r=1&oref=slogin
Generic competition, a dearth of new drugs and a more safety-conscious posture by the
Food and Drug Administration are among factors that have led to the announcements of at least 35,000 industry layoffs during the last year, industry analysts said.
...
Industrywide, drugs with combined annual sales estimated at $60 billion will lose patent protection in the next five years. That reality is frequently cited for layoffs at drug companies, including
Pfizer, the world’s biggest drug maker, which has announced job cuts of about 10,000 in the past year, or about 10 percent of its work force.
Johnson & Johnson said this year that it would cut 4,800 position, or about 4 percent of its employees.
Merck announced a global revamping in November 2005 that included an overall work force reduction of about 10 percent. There have already been 6,000 jobs cut, and the company is expected to lay off 1,000 more workers by the end of next year.
James Kumpel, an analyst for the investment house Friedman, Billings, Ramsey, said that part of the problem facing drug makers was an increasingly cautious F.D.A.
This year through October, the agency approved only 14 new molecular entities — drugs that are entirely new compounds rather than changes in formulations. That is a decline of about 18 percent from the comparable period in 2006, and it is well below recent norms, according to Mr. Kumpel’s analysis.
Mr. Kumpel said the trend appeared to reflect the lowest rate of F.D.A. approvals since 1994.
“If the F.D.A. is not allowing drugs to get to the market, or is just holding them to much tougher standards than before, drug makers face the prospect of a lot of new drugs going off patent and no new blockbusters to take their place,” Mr. Kumpel said